Obstructive sleep apnoea and metabolic syndrome: Two sides of the same coin?

Journal of Human Hypertension

Volumn 22, Issue 6, 2008, Pages 377-379

  Dwivedi, G ^a   Khair, O ^a   Lip, G Y H ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HYDROCORTISONE; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ARTERIAL STIFFNESS; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CAUSAL ATTRIBUTION; CLINICAL TRIAL; COMORBIDITY; DEATH; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; HEAD AND NECK SURGERY; HEART ARRHYTHMIA; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; HYPOXIA; INSULIN RESISTANCE; METABOLIC SYNDROME X; NOTE; OBESITY; PATHOGENESIS; POSITIVE END EXPIRATORY PRESSURE; RISK FACTOR; SLEEP APNEA SYNDROME; SMOKING; STROKE; SYMPATHETIC TONE; THERAPY EFFECT; TREATMENT FAILURE; WEIGHT GAIN;

ARTERIES; CARDIOVASCULAR DISEASES; CONTINUOUS POSITIVE AIRWAY PRESSURE; HUMANS; INSULIN RESISTANCE; METABOLIC SYNDROME X; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE; WEIGHT GAIN;

EID: 44049087608     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2008.14     Document Type: Note

References (20)

1. Marin JM, Carrizo SI, Vincnte E, Agusti AGN. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or wititout treatment with continuous positive airway pressure: An observational study. Lancet 2005; 365: 1046-1053.
2. Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 2005; 353: 2034-2041.
3. Quan SF, Gersh BJ. Cardiovascular consequences of sleep-disordered breathing: Past, present, and future. Report of a workshop from National Center On Sleep Disorders Research and The National Heart, Lung and Blood Institute. Circulation 2004; 109: 951-957.
4. Foster GE, Poulin MJ, Hanly PJ. Intermittent hypoxia and vascular function: Implications for obstructive sleep apnoea. Exp Physiol 2007; 92: 51-65.
5. Drager LF, Bortolotto LA, Lorenzi MC, Figueiredo AC, Krieger EM, Lorenzi-Filho G. Early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care 2005; 172: 613-618.
6. Baguet, JP, Hammer L, Levy P, Pierre H, Launois S, Mallion JM et al The sensitivity of oxygen desaturation is predictive of carotid wall thickening and plaque occurrence. Chest 2005; 128: 34074-3412.
7. Phillips C, Hedner J, Berend N, Grunstein R. Diurnal and obstructive sleep apnea influences on arterial stiffness and central blood pressure in men. Sleep 2005; 28: 604-609.
8. Protogerou AD, Laabaub J-P, Czernichowa S, Kostopoulosc C, Lekakisd J, Safara ME et al. Structural and functional arterial properties in patients with obstructive sleep apnea syndrome and cardiovascular comorbidities. J Hum Hypertens 2008; 22: 415-422 (this issue).
9. Bray GA, Bellanger T. Epidemiology, trends and morbidities of obesity and the metabolic syndrome. Endocrine 2006; 29: 109-118.
10. Grundy SM. Metabolic syndrome: Connecting and reconciling cardiovascular and diabetes worlds. J Am Coll Cardiol 2006; 47: 1093-1100.
11. Shamsuzzaman ASM, Gersh BJ, Somers VK. Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA 2003; 290 1906-1914.
12. Vgontzas AN, Bixler EO, Chrousos GP. Sleep apnea is a manifestation of the metabolic syndrome. Sleep Med Rev 2005; 9: 211-224.
13. Strohl KP, Redline S. Recognition of obstructive sleep apnea. Am J Respir Crit Care Med 1996; 154: 279-289.
14. Smith PL, Schwartz AR. Biomechanics of the upper airway during sleep. In: Pack AI (ed). Sleep Apnea: Pathogenesis, Diagnosis, and Treatment vol 166, pp 31-56.
15. Gopal M, Duntley S, Uhles M, Attarian H. The role of obesity in the increased prevalence of obstructive sleep apnea syndrome in patients with polycystic ovarian syndrome. Sleep Med 2002; 3: 401-404.
16. Park Y-W, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome. Prevalence and associated risk factor findings in the US population from the third national health and nutrition examination survey, 1988-1994. Arch Intern Med 2003; 163: 427-436.
17. Koji Y, Tomiyama H, Yamada J, Yambe M, Motobe K, Shiina K et al. Relationship between arterial stiffness and the risk of coronary artery disease in subjects with and without metabolic syndrome. Hypertens Res 2007; 30: 243-247.
18. Iannuzzi A, Licenziati MR, Acampora C, De Michele M, Iannuzzo G, Chiariello G et al. Carotid artery wall hypertrophy in children with metabolic syndrome. J Hum Hypertens 2007; 22: 83-88.
19. Ferrara LA, Cardoni O, Mancini M, Zanchetti A. Metabolic syndrome and left ventricular hypetrophy in a general population. Results from the Gubbio Study. J Hum Hypertens 2007; 21: 795-801.
20. de Simone G, Olsen MH, Wachtell K, Hille DA, Dahlöf B, Ibsen H et al. Clusters of metabolic risk factors predict cardiovascular events in hypertension with target-organ damage: The LIFE study. J Hum Hypertens 2007; 21: 625-632.